| 0 |
POST GASTRIC SURGERY SYNDROME |
1 |
0.0111 |
| 1 |
BLEEDING TIME ABNORMAL |
1 |
0.0097 |
| 2 |
MANUFACTURING PRODUCTION ISSUE |
1 |
0.0096 |
| 3 |
GALLOP RHYTHM PRESENT |
1 |
0.0084 |
| 4 |
PILONIDAL DISEASE |
1 |
0.0042 |
| 5 |
ANORECTAL INFECTION |
1 |
0.0040 |
| 6 |
ANTICOAGULANT THERAPY |
1 |
0.0035 |
| 7 |
MEDICATION OVERUSE HEADACHE |
3 |
0.0035 |
| 8 |
WHITE BLOOD CELL COUNT |
1 |
0.0034 |
| 9 |
VISUAL ACUITY REDUCED TRANSIENTLY |
1 |
0.0032 |
| 10 |
HEPATIC VEIN THROMBOSIS |
1 |
0.0032 |
| 11 |
PERIPHERAL NERVE LESION |
1 |
0.0030 |
| 12 |
CREATININE RENAL CLEARANCE INCREASED |
2 |
0.0027 |
| 13 |
NSAID EXACERBATED RESPIRATORY DISEASE |
1 |
0.0026 |
| 14 |
ACCELERATED HYPERTENSION |
1 |
0.0026 |
| 15 |
HOUSEBOUND |
1 |
0.0025 |
| 16 |
OESOPHAGEAL DILATATION |
1 |
0.0023 |
| 17 |
INFUSION SITE SCAR |
1 |
0.0023 |
| 18 |
OESOPHAGEAL INFECTION |
1 |
0.0022 |
| 19 |
HYPERVIGILANCE |
2 |
0.0021 |
| 20 |
ORAL LICHEN PLANUS |
1 |
0.0020 |
| 21 |
POSTNASAL DRIP |
1 |
0.0018 |
| 22 |
BLOOD BILIRUBIN DECREASED |
1 |
0.0016 |
| 23 |
INTESTINAL FUNCTIONAL DISORDER |
1 |
0.0016 |
| 24 |
INTENTIONAL MISUSE |
3 |
0.0016 |
| 25 |
SPUTUM PURULENT |
1 |
0.0015 |
| 26 |
DELIVERY |
1 |
0.0015 |
| 27 |
BLOOD LACTATE DEHYDROGENASE ABNORMAL |
1 |
0.0015 |
| 28 |
ARTHROSCOPY |
1 |
0.0015 |
| 29 |
MULTIPLE DRUG THERAPY |
1 |
0.0013 |
| 30 |
ARTERIAL RUPTURE |
1 |
0.0013 |
| 31 |
ALTERED VISUAL DEPTH PERCEPTION |
1 |
0.0012 |
| 32 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
1 |
0.0012 |
| 33 |
EROSIVE OESOPHAGITIS |
2 |
0.0012 |
| 34 |
SEDATION COMPLICATION |
3 |
0.0012 |
| 35 |
MALIGNANT HYPERTENSION |
1 |
0.0012 |
| 36 |
HEART TRANSPLANT |
1 |
0.0011 |
| 37 |
BONE CONTUSION |
1 |
0.0011 |
| 38 |
PRODUCT APPEARANCE CONFUSION |
1 |
0.0011 |
| 39 |
PROSTATE INFECTION |
1 |
0.0010 |
| 40 |
RED BLOOD CELLS URINE POSITIVE |
1 |
0.0010 |
| 41 |
HYPOGEUSIA |
2 |
0.0010 |
| 42 |
OROPHARYNGEAL SWELLING |
1 |
0.0010 |
| 43 |
NASAL INFLAMMATION |
1 |
0.0009 |
| 44 |
PRODUCT COMMINGLING |
1 |
0.0009 |
| 45 |
GASTROINTESTINAL ULCER |
2 |
0.0009 |
| 46 |
URINARY TRACT DISORDER |
4 |
0.0009 |
| 47 |
BLOODY DISCHARGE |
1 |
0.0009 |
| 48 |
LIBIDO DISORDER |
1 |
0.0008 |
| 49 |
IMPLANTABLE DEFIBRILLATOR INSERTION |
1 |
0.0008 |
| 50 |
CREATININE RENAL CLEARANCE DECREASED |
3 |
0.0007 |
| 51 |
TONGUE DRY |
1 |
0.0007 |
| 52 |
EFFUSION |
1 |
0.0007 |
| 53 |
SUDDEN ONSET OF SLEEP |
1 |
0.0007 |
| 54 |
APPENDIX DISORDER |
1 |
0.0007 |
| 55 |
GENITAL RASH |
1 |
0.0007 |
| 56 |
GASTRITIS HAEMORRHAGIC |
1 |
0.0007 |
| 57 |
HYPOAESTHESIA FACIAL |
1 |
0.0007 |
| 58 |
HYPOSMIA |
1 |
0.0007 |
| 59 |
BLOOD PRESSURE IMMEASURABLE |
1 |
0.0007 |
| 60 |
VASCULAR RUPTURE |
1 |
0.0006 |
| 61 |
INTRA-UTERINE DEATH |
1 |
0.0006 |
| 62 |
COSTOCHONDRITIS |
1 |
0.0006 |
| 63 |
LAZINESS |
1 |
0.0006 |
| 64 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 65 |
BLOOD AMYLASE INCREASED |
1 |
0.0006 |
| 66 |
SPONDYLOLISTHESIS |
1 |
0.0006 |
| 67 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 68 |
SKIN HYPOPIGMENTATION |
1 |
0.0006 |
| 69 |
MITRAL VALVE DISEASE |
1 |
0.0006 |
| 70 |
INTRA-ABDOMINAL FLUID COLLECTION |
1 |
0.0006 |
| 71 |
HYPERTRICHOSIS |
1 |
0.0005 |
| 72 |
WHITE BLOOD CELLS URINE POSITIVE |
1 |
0.0005 |
| 73 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 74 |
PANCREATIC CYST |
1 |
0.0005 |
| 75 |
PRODUCT ODOUR ABNORMAL |
5 |
0.0005 |
| 76 |
DILATATION VENTRICULAR |
1 |
0.0005 |
| 77 |
INTERVERTEBRAL DISC DISORDER |
2 |
0.0005 |
| 78 |
RHEUMATIC FEVER |
2 |
0.0004 |
| 79 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 80 |
KOUNIS SYNDROME |
1 |
0.0004 |
| 81 |
RENAL FUNCTION TEST ABNORMAL |
2 |
0.0004 |
| 82 |
INFUSION SITE INFECTION |
1 |
0.0004 |
| 83 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 84 |
GASTRITIS EROSIVE |
2 |
0.0004 |
| 85 |
SINUS PAIN |
1 |
0.0004 |
| 86 |
PATELLA FRACTURE |
1 |
0.0004 |
| 87 |
PRURITUS GENITAL |
1 |
0.0004 |
| 88 |
SPINAL DISORDER |
4 |
0.0004 |
| 89 |
PUSTULE |
1 |
0.0004 |
| 90 |
ORAL INTAKE REDUCED |
1 |
0.0004 |
| 91 |
SLOW SPEECH |
1 |
0.0004 |
| 92 |
PRODUCT PACKAGING CONFUSION |
1 |
0.0004 |
| 93 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 94 |
MULTIPLE DRUG OVERDOSE |
2 |
0.0004 |
| 95 |
VENTRICULAR HYPERTROPHY |
1 |
0.0004 |
| 96 |
VASODILATATION |
1 |
0.0004 |
| 97 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 98 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 99 |
MENOPAUSE |
1 |
0.0004 |
| 100 |
HERNIA REPAIR |
1 |
0.0004 |
| 101 |
RETINAL DISORDER |
1 |
0.0004 |
| 102 |
EAR CONGESTION |
1 |
0.0004 |
| 103 |
DRUG TOXICITY |
5 |
0.0004 |
| 104 |
JOINT LOCK |
1 |
0.0004 |
| 105 |
DUODENAL ULCER HAEMORRHAGE |
1 |
0.0003 |
| 106 |
EYELID MARGIN CRUSTING |
1 |
0.0003 |
| 107 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 108 |
LUMBAR SPINAL STENOSIS |
1 |
0.0003 |
| 109 |
BLEPHAROSPASM |
2 |
0.0003 |
| 110 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 111 |
FAECAL CALPROTECTIN INCREASED |
1 |
0.0003 |
| 112 |
MULTIPLE DRUG OVERDOSE INTENTIONAL |
1 |
0.0003 |
| 113 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 114 |
THERAPEUTIC AGENT TOXICITY |
1 |
0.0003 |
| 115 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 116 |
VIITH NERVE PARALYSIS |
1 |
0.0003 |
| 117 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
0.0003 |
| 118 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
1 |
0.0003 |
| 119 |
LUNG TRANSPLANT |
1 |
0.0003 |
| 120 |
MACULOPATHY |
1 |
0.0003 |
| 121 |
SKIN WEEPING |
1 |
0.0003 |
| 122 |
SPONDYLITIS |
1 |
0.0003 |
| 123 |
DEVICE KINK |
1 |
0.0003 |
| 124 |
RECTAL DISCHARGE |
1 |
0.0003 |
| 125 |
BLOOD CALCIUM DECREASED |
3 |
0.0003 |
| 126 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 127 |
GASTRIC HAEMORRHAGE |
3 |
0.0003 |
| 128 |
OESOPHAGEAL ULCER |
1 |
0.0003 |
| 129 |
FAECES HARD |
1 |
0.0003 |
| 130 |
IMMOBILE |
1 |
0.0002 |
| 131 |
GRIP STRENGTH DECREASED |
2 |
0.0002 |
| 132 |
IRON DEFICIENCY |
1 |
0.0002 |
| 133 |
PRODUCT TASTE ABNORMAL |
3 |
0.0002 |
| 134 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 135 |
EXOSTOSIS |
2 |
0.0002 |
| 136 |
INTERVERTEBRAL DISC DEGENERATION |
2 |
0.0002 |
| 137 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 138 |
GASTRIC ULCER |
4 |
0.0002 |
| 139 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 140 |
LIMB OPERATION |
1 |
0.0002 |
| 141 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 142 |
BLADDER DISORDER |
2 |
0.0002 |
| 143 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 144 |
HYPERAMMONAEMIA |
1 |
0.0002 |
| 145 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 146 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 147 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 148 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 149 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 150 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 151 |
ANAL FISSURE |
1 |
0.0002 |
| 152 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 153 |
NORMAL NEWBORN |
1 |
0.0002 |
| 154 |
ASTHENOPIA |
1 |
0.0002 |
| 155 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 156 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 157 |
REBOUND EFFECT |
2 |
0.0002 |
| 158 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 159 |
PERONEAL NERVE PALSY |
1 |
0.0002 |
| 160 |
SCAR |
3 |
0.0002 |
| 161 |
MADAROSIS |
2 |
0.0002 |
| 162 |
ORTHOSTATIC HYPOTENSION |
3 |
0.0002 |
| 163 |
RALES |
1 |
0.0002 |
| 164 |
SKIN WARM |
1 |
0.0002 |
| 165 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 166 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 167 |
ENERGY INCREASED |
1 |
0.0002 |
| 168 |
SINUS HEADACHE |
1 |
0.0002 |
| 169 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 170 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 171 |
SCOLIOSIS |
1 |
0.0002 |
| 172 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 173 |
PHOTOPHOBIA |
3 |
0.0002 |
| 174 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 175 |
PHOTOPSIA |
1 |
0.0002 |
| 176 |
HIATUS HERNIA |
2 |
0.0002 |
| 177 |
SEDATION |
4 |
0.0002 |
| 178 |
POLYP |
1 |
0.0002 |
| 179 |
SOMNAMBULISM |
1 |
0.0002 |
| 180 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 181 |
SINUS DISORDER |
3 |
0.0002 |
| 182 |
BREAST MASS |
1 |
0.0001 |
| 183 |
BRONCHIECTASIS |
1 |
0.0001 |
| 184 |
INFARCTION |
1 |
0.0001 |
| 185 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 186 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 187 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 188 |
EXTRASYSTOLES |
1 |
0.0001 |
| 189 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 190 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 191 |
METASTASIS |
1 |
0.0001 |
| 192 |
INJECTION SITE HAEMATOMA |
2 |
0.0001 |
| 193 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 194 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 195 |
FEELING DRUNK |
1 |
0.0001 |
| 196 |
GENERAL SYMPTOM |
1 |
0.0001 |
| 197 |
PAROSMIA |
1 |
0.0001 |
| 198 |
ACIDOSIS |
1 |
0.0001 |
| 199 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 200 |
LIPASE INCREASED |
1 |
0.0001 |
| 201 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 202 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 203 |
CONCUSSION |
1 |
0.0001 |
| 204 |
APHTHOUS ULCER |
1 |
0.0001 |
| 205 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 206 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 207 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 208 |
MOBILITY DECREASED |
9 |
0.0001 |
| 209 |
MIOSIS |
1 |
0.0001 |
| 210 |
ABNORMAL FAECES |
1 |
0.0001 |
| 211 |
VENTRICULAR TACHYCARDIA |
2 |
0.0001 |
| 212 |
VIRAL INFECTION |
4 |
0.0001 |
| 213 |
COMPLETED SUICIDE |
10 |
0.0001 |
| 214 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 215 |
FACE OEDEMA |
2 |
0.0001 |
| 216 |
SKIN PLAQUE |
1 |
0.0001 |
| 217 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 218 |
CARDIAC MURMUR |
1 |
0.0001 |
| 219 |
PYELONEPHRITIS |
1 |
0.0001 |
| 220 |
SKIN SWELLING |
1 |
0.0001 |
| 221 |
GASTRITIS |
3 |
0.0001 |
| 222 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 223 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 224 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 225 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 226 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 227 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 228 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 229 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 230 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 231 |
HAEMORRHOIDS |
2 |
0.0001 |
| 232 |
HEPATOMEGALY |
1 |
0.0001 |
| 233 |
HOSPICE CARE |
1 |
0.0001 |
| 234 |
EMPHYSEMA |
1 |
0.0001 |
| 235 |
DRY THROAT |
1 |
0.0001 |
| 236 |
DRUG ADMINISTRATION ERROR |
3 |
0.0001 |
| 237 |
EUPHORIC MOOD |
1 |
0.0001 |
| 238 |
RIB FRACTURE |
2 |
0.0001 |
| 239 |
EYE DISCHARGE |
1 |
0.0001 |
| 240 |
JOINT DISLOCATION |
1 |
0.0001 |
| 241 |
SUDDEN DEATH |
1 |
0.0001 |
| 242 |
CYSTITIS |
3 |
0.0001 |
| 243 |
INTENTIONAL OVERDOSE |
6 |
0.0001 |
| 244 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 245 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 246 |
POOR QUALITY SLEEP |
2 |
0.0001 |
| 247 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 248 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 249 |
OESOPHAGITIS |
1 |
0.0001 |
| 250 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 251 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 252 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 253 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 254 |
GASTRIC DISORDER |
3 |
0.0001 |
| 255 |
NEOPLASM |
1 |
0.0001 |
| 256 |
UNINTENTIONAL MEDICAL DEVICE REMOVAL |
1 |
0.0001 |
| 257 |
EYELID OEDEMA |
1 |
0.0001 |
| 258 |
COGNITIVE DISORDER |
4 |
0.0001 |
| 259 |
SPINAL PAIN |
1 |
0.0001 |
| 260 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 261 |
MIGRAINE |
8 |
0.0001 |
| 262 |
ACCIDENT |
1 |
0.0001 |
| 263 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 264 |
CARDIOMEGALY |
1 |
0.0001 |
| 265 |
SPINAL OPERATION |
1 |
0.0001 |
| 266 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 267 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 268 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
4 |
0.0001 |
| 269 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 270 |
TOOTH INFECTION |
1 |
0.0001 |
| 271 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 272 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 273 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 274 |
UVEITIS |
1 |
0.0001 |
| 275 |
TACHYPNOEA |
1 |
0.0001 |
| 276 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
1 |
0.0001 |
| 277 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 278 |
DRUG ABUSE |
6 |
0.0001 |
| 279 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 280 |
MASS |
1 |
0.0001 |
| 281 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 282 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 283 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 284 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 285 |
DIALYSIS |
1 |
0.0001 |
| 286 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 287 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 288 |
PARALYSIS |
1 |
0.0001 |
| 289 |
BALANCE DISORDER |
6 |
0.0001 |
| 290 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 291 |
ANOSMIA |
1 |
0.0001 |
| 292 |
HYPOKINESIA |
1 |
0.0001 |
| 293 |
UNDERDOSE |
5 |
0.0001 |
| 294 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 295 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 296 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 297 |
HEPATIC FAILURE |
2 |
0.0001 |
| 298 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 299 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 300 |
STOMATITIS |
4 |
0.0001 |
| 301 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 302 |
SKIN IRRITATION |
3 |
0.0001 |
| 303 |
INSURANCE ISSUE |
1 |
0.0001 |
| 304 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 305 |
FEMUR FRACTURE |
2 |
0.0001 |
| 306 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 307 |
CONSTIPATION |
14 |
0.0001 |
| 308 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 309 |
HEAD INJURY |
2 |
0.0001 |
| 310 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 311 |
BLOOD GLUCOSE DECREASED |
3 |
0.0001 |
| 312 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 313 |
CHOLELITHIASIS |
2 |
0.0001 |
| 314 |
MANIA |
1 |
0.0001 |
| 315 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 316 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 317 |
DRY EYE |
3 |
0.0001 |
| 318 |
COAGULOPATHY |
1 |
0.0001 |
| 319 |
CELLULITIS |
3 |
0.0001 |
| 320 |
PRODUCT QUALITY ISSUE |
8 |
0.0001 |
| 321 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 322 |
PARANOIA |
1 |
0.0001 |
| 323 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 324 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 325 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 326 |
MUSCULOSKELETAL STIFFNESS |
5 |
0.0001 |
| 327 |
METASTASES TO LIVER |
1 |
0.0001 |
| 328 |
COLD SWEAT |
1 |
0.0001 |
| 329 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 330 |
PRODUCT ADHESION ISSUE |
2 |
0.0001 |
| 331 |
OSTEOMYELITIS |
1 |
0.0001 |
| 332 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 333 |
TREATMENT NONCOMPLIANCE |
3 |
0.0001 |
| 334 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 335 |
AGITATION |
4 |
0.0001 |
| 336 |
BRONCHITIS |
4 |
0.0001 |
| 337 |
MEDICATION ERROR |
3 |
0.0001 |
| 338 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 339 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 340 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 341 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 342 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 343 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 344 |
FLATULENCE |
3 |
0.0001 |
| 345 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 346 |
FOOT FRACTURE |
1 |
0.0001 |
| 347 |
PROTEINURIA |
1 |
0.0001 |
| 348 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 349 |
GLAUCOMA |
1 |
0.0001 |
| 350 |
HERNIA |
1 |
0.0001 |
| 351 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 352 |
PALPITATIONS |
6 |
0.0001 |
| 353 |
ORAL HERPES |
1 |
0.0001 |
| 354 |
SURGERY |
3 |
0.0001 |
| 355 |
SKIN FISSURES |
1 |
0.0001 |
| 356 |
KIDNEY INFECTION |
1 |
0.0001 |
| 357 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 358 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 359 |
SOMNOLENCE |
10 |
0.0000 |
| 360 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 361 |
FEEDING DISORDER |
1 |
0.0000 |
| 362 |
TASTE DISORDER |
1 |
0.0000 |
| 363 |
FLUSHING |
5 |
0.0000 |
| 364 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 365 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 366 |
POLLAKIURIA |
2 |
0.0000 |
| 367 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 368 |
DERMATITIS |
1 |
0.0000 |
| 369 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 370 |
TOXICITY TO VARIOUS AGENTS |
8 |
0.0000 |
| 371 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 372 |
OSTEOARTHRITIS |
2 |
0.0000 |
| 373 |
EATING DISORDER |
1 |
0.0000 |
| 374 |
URINARY TRACT INFECTION |
8 |
0.0000 |
| 375 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 376 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 377 |
RECTAL HAEMORRHAGE |
2 |
0.0000 |
| 378 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 379 |
TOOTH DISORDER |
1 |
0.0000 |
| 380 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 381 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 382 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 383 |
CHROMATURIA |
1 |
0.0000 |
| 384 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 385 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 386 |
ABDOMINAL PAIN UPPER |
9 |
0.0000 |
| 387 |
TINNITUS |
2 |
0.0000 |
| 388 |
SHOCK |
1 |
0.0000 |
| 389 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 390 |
HYPERTENSION |
9 |
0.0000 |
| 391 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 392 |
FEELING ABNORMAL |
10 |
0.0000 |
| 393 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 394 |
LOCALISED INFECTION |
1 |
0.0000 |
| 395 |
NEURALGIA |
1 |
0.0000 |
| 396 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 397 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 398 |
ABASIA |
1 |
0.0000 |
| 399 |
AGEUSIA |
1 |
0.0000 |
| 400 |
COVID-19 |
7 |
0.0000 |
| 401 |
HYPOTENSION |
8 |
0.0000 |
| 402 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 403 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 404 |
WEIGHT DECREASED |
11 |
0.0000 |
| 405 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 406 |
HYPOPHAGIA |
1 |
0.0000 |
| 407 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 408 |
SINUSITIS |
4 |
0.0000 |
| 409 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 410 |
INFLAMMATION |
2 |
0.0000 |
| 411 |
BACK PAIN |
9 |
0.0000 |
| 412 |
SKIN ULCER |
1 |
0.0000 |
| 413 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 414 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 415 |
NERVOUSNESS |
2 |
0.0000 |
| 416 |
ECZEMA |
2 |
0.0000 |
| 417 |
DRUG INTERACTION |
6 |
0.0000 |
| 418 |
CHEST PAIN |
7 |
0.0000 |
| 419 |
BRADYCARDIA |
2 |
0.0000 |
| 420 |
EAR INFECTION |
1 |
0.0000 |
| 421 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 422 |
FEAR |
1 |
0.0000 |
| 423 |
JAUNDICE |
1 |
0.0000 |
| 424 |
PAIN OF SKIN |
1 |
0.0000 |
| 425 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 426 |
ANAEMIA |
7 |
0.0000 |
| 427 |
MOOD ALTERED |
1 |
0.0000 |
| 428 |
PRURITUS |
14 |
0.0000 |
| 429 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 430 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 431 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 432 |
FEELING COLD |
1 |
0.0000 |
| 433 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 434 |
INFLUENZA |
4 |
0.0000 |
| 435 |
HAEMOPTYSIS |
1 |
0.0000 |
| 436 |
DEMENTIA |
1 |
0.0000 |
| 437 |
EYE PAIN |
2 |
0.0000 |
| 438 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 439 |
ANGINA PECTORIS |
1 |
0.0000 |
| 440 |
HYPERSOMNIA |
1 |
0.0000 |
| 441 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 442 |
NAUSEA |
27 |
0.0000 |
| 443 |
NASAL CONGESTION |
2 |
0.0000 |
| 444 |
ASCITES |
1 |
0.0000 |
| 445 |
PRODUCT DOSE OMISSION ISSUE |
10 |
0.0000 |
| 446 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 447 |
CATARACT |
2 |
0.0000 |
| 448 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 449 |
APHASIA |
1 |
0.0000 |
| 450 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 451 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 452 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 453 |
CONDITION AGGRAVATED |
10 |
0.0000 |
| 454 |
VERTIGO |
2 |
0.0000 |
| 455 |
DISCOMFORT |
2 |
0.0000 |
| 456 |
EPILEPSY |
1 |
0.0000 |
| 457 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 458 |
OVERDOSE |
7 |
0.0000 |
| 459 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 460 |
GYNAECOMASTIA |
1 |
0.0000 |
| 461 |
COUGH |
9 |
0.0000 |
| 462 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 463 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 464 |
HEADACHE |
20 |
0.0000 |
| 465 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 466 |
PARAESTHESIA |
5 |
0.0000 |
| 467 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 468 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 469 |
HIP FRACTURE |
1 |
0.0000 |
| 470 |
PNEUMONIA |
10 |
0.0000 |
| 471 |
SWELLING FACE |
2 |
0.0000 |
| 472 |
DYSPEPSIA |
3 |
0.0000 |
| 473 |
IMPAIRED HEALING |
1 |
0.0000 |
| 474 |
EYE DISORDER |
1 |
0.0000 |
| 475 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 476 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 477 |
LIP SWELLING |
1 |
0.0000 |
| 478 |
URINARY RETENTION |
1 |
0.0000 |
| 479 |
DRY SKIN |
4 |
0.0000 |
| 480 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 481 |
MYALGIA |
5 |
0.0000 |
| 482 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 483 |
ASTHENIA |
11 |
0.0000 |
| 484 |
HAEMATURIA |
1 |
0.0000 |
| 485 |
VISION BLURRED |
4 |
0.0000 |
| 486 |
NIGHTMARE |
1 |
0.0000 |
| 487 |
HAEMORRHAGE |
3 |
0.0000 |
| 488 |
SLEEP DISORDER |
2 |
0.0000 |
| 489 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 490 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
0.0000 |
| 491 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 492 |
INFECTION |
4 |
0.0000 |
| 493 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 494 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 495 |
DYSURIA |
1 |
0.0000 |
| 496 |
FALL |
9 |
0.0000 |
| 497 |
HYPERSENSITIVITY |
5 |
0.0000 |
| 498 |
DYSGEUSIA |
2 |
0.0000 |
| 499 |
DYSARTHRIA |
1 |
0.0000 |
| 500 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 501 |
HOT FLUSH |
2 |
0.0000 |
| 502 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 503 |
DIARRHOEA |
17 |
0.0000 |
| 504 |
GAIT DISTURBANCE |
5 |
0.0000 |
| 505 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 506 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 507 |
DISORIENTATION |
1 |
0.0000 |
| 508 |
OFF LABEL USE |
22 |
0.0000 |
| 509 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 510 |
DRY MOUTH |
2 |
0.0000 |
| 511 |
BLINDNESS |
1 |
0.0000 |
| 512 |
FATIGUE |
19 |
0.0000 |
| 513 |
OSTEOPOROSIS |
1 |
0.0000 |
| 514 |
CARDIAC ARREST |
2 |
0.0000 |
| 515 |
DIZZINESS |
12 |
0.0000 |
| 516 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 517 |
VOMITING |
11 |
0.0000 |
| 518 |
HYPERHIDROSIS |
3 |
0.0000 |
| 519 |
HYPOACUSIS |
1 |
0.0000 |
| 520 |
MENTAL DISORDER |
1 |
0.0000 |
| 521 |
DYSPNOEA |
13 |
0.0000 |
| 522 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 523 |
MALAISE |
10 |
0.0000 |
| 524 |
PAIN |
14 |
0.0000 |
| 525 |
ANGIOEDEMA |
1 |
0.0000 |
| 526 |
RENAL FAILURE |
3 |
0.0000 |
| 527 |
LIVER DISORDER |
1 |
0.0000 |
| 528 |
TACHYCARDIA |
2 |
0.0000 |
| 529 |
DEHYDRATION |
3 |
0.0000 |
| 530 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 531 |
THROAT IRRITATION |
1 |
0.0000 |
| 532 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 533 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 534 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 535 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 536 |
ADVERSE EVENT |
2 |
0.0000 |
| 537 |
HYPOKALAEMIA |
1 |
0.0000 |
| 538 |
ARTHRALGIA |
9 |
0.0000 |
| 539 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 540 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 541 |
RENAL DISORDER |
1 |
0.0000 |
| 542 |
ARRHYTHMIA |
1 |
0.0000 |
| 543 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 544 |
RENAL CANCER |
1 |
0.0000 |
| 545 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 546 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 547 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 548 |
LUNG DISORDER |
1 |
0.0000 |
| 549 |
PAIN IN EXTREMITY |
6 |
0.0000 |
| 550 |
SYNCOPE |
2 |
0.0000 |
| 551 |
AGGRESSION |
1 |
0.0000 |
| 552 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
4 |
0.0000 |
| 553 |
DRUG INEFFECTIVE |
26 |
0.0000 |
| 554 |
FLUID RETENTION |
1 |
0.0000 |
| 555 |
THERAPY CESSATION |
1 |
0.0000 |
| 556 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 557 |
ERYTHEMA |
4 |
0.0000 |
| 558 |
ILLNESS |
2 |
0.0000 |
| 559 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 560 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 561 |
SPEECH DISORDER |
1 |
0.0000 |
| 562 |
PANCREATITIS |
1 |
0.0000 |
| 563 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 564 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 565 |
RASH PRURITIC |
1 |
0.0000 |
| 566 |
OEDEMA |
1 |
0.0000 |
| 567 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 568 |
SEPSIS |
2 |
0.0000 |
| 569 |
URTICARIA |
3 |
0.0000 |
| 570 |
BLISTER |
1 |
0.0000 |
| 571 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 572 |
DEPRESSION |
4 |
0.0000 |
| 573 |
CONVULSION |
1 |
0.0000 |
| 574 |
HERPES ZOSTER |
1 |
0.0000 |
| 575 |
LETHARGY |
1 |
0.0000 |
| 576 |
EYE IRRITATION |
1 |
0.0000 |
| 577 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 578 |
DECREASED APPETITE |
4 |
0.0000 |
| 579 |
BONE PAIN |
1 |
0.0000 |
| 580 |
BLADDER CANCER |
1 |
0.0000 |
| 581 |
IRRITABILITY |
1 |
0.0000 |
| 582 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 583 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 584 |
FEELING HOT |
1 |
0.0000 |
| 585 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 586 |
RHINORRHOEA |
1 |
0.0000 |
| 587 |
AMNESIA |
1 |
0.0000 |
| 588 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 589 |
ALOPECIA |
3 |
0.0000 |
| 590 |
INSOMNIA |
4 |
0.0000 |
| 591 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 592 |
PYREXIA |
5 |
0.0000 |
| 593 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 594 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 595 |
ANXIETY |
4 |
0.0000 |
| 596 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 597 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 598 |
RASH |
6 |
0.0000 |
| 599 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 600 |
WEIGHT INCREASED |
3 |
0.0000 |
| 601 |
EPISTAXIS |
1 |
0.0000 |
| 602 |
HYPOAESTHESIA |
2 |
0.0000 |
| 603 |
HALLUCINATION |
1 |
0.0000 |
| 604 |
ACNE |
1 |
0.0000 |
| 605 |
DIABETES MELLITUS |
1 |
0.0000 |
| 606 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 607 |
ARTHRITIS |
1 |
0.0000 |
| 608 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 609 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 610 |
CARDIAC FAILURE |
1 |
0.0000 |
| 611 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 612 |
DRUG DEPENDENCE |
2 |
0.0000 |
| 613 |
PROSTATE CANCER |
1 |
0.0000 |
| 614 |
THROMBOSIS |
1 |
0.0000 |
| 615 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 616 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 617 |
DEVICE ISSUE |
1 |
0.0000 |
| 618 |
MUSCLE SPASMS |
2 |
0.0000 |
| 619 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 620 |
CONTUSION |
1 |
0.0000 |
| 621 |
HEART RATE INCREASED |
1 |
0.0000 |
| 622 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 623 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 624 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 625 |
SEIZURE |
1 |
0.0000 |
| 626 |
CHILLS |
1 |
0.0000 |
| 627 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 628 |
JOINT SWELLING |
1 |
0.0000 |
| 629 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 630 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 631 |
PSORIASIS |
1 |
0.0000 |
| 632 |
DEATH |
6 |
0.0000 |
| 633 |
HOSPITALISATION |
1 |
0.0000 |
| 634 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 635 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 636 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 637 |
TREMOR |
1 |
0.0000 |
| 638 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 639 |
PRODUCT USE ISSUE |
1 |
0.0000 |